Predictive Markers of First Line Pazopanib Treatment in Kidney Cancer

Real-world evidence from clinical practices is fundamental for understanding the efficacy and tolerability of medicinal products. Patients with renal cell cancer were studied to gain data not represented by analyses conducted on highly selected patients participating in clinical trials. Our goal was...

Descripción completa

Detalles Bibliográficos
Autores principales: Küronya, Zsófia, Szőnyi, Mihály Dániel, Nagyiványi, Krisztián, Gyergyay, Fruzsina, Géczi, Lajos, Budai, Barna, Martin, Tamás, Ladányi, Andrea, Kiss, Edina, Biró, Krisztina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471165/
https://www.ncbi.nlm.nih.gov/pubmed/32572819
http://dx.doi.org/10.1007/s12253-020-00853-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471165/
https://www.ncbi.nlm.nih.gov/pubmed/32572819
http://dx.doi.org/10.1007/s12253-020-00853-9

Ejemplares similares